Rheumnow Podcast

Opioids and Health Care Utilization in PsA and AS Reproductive health in a post-Roe world Spondyloarthritis: Novel Therapies, Diagnostic Dilemmas and Depression Sunday (Day 2): ACR 22 Daily Recap Tapering TNFi in nonradiographic AxSpA The CONSUL Trial: Ankylosing Spondylitis

Comorbidities in Ankylosing Spondylitis Early Diagnosis of Axial Spondyloarthritis Fertility issues in SpA Gender in AxSpa Inadequate Dosing of Hydroxychloroquine Leads to Hospitalizations in SLE JAK inhibitors in rheumatic diseases Opioid use in PsA and SpA

ACR22 Daily Recap: Saturday Recap AI Future of Sacroiliitis Assessment Artificial Intelligence in Detecting Sacroiliitis Axial Spondyloarthritis: gender differences Can we alter neonatal gut microbiome to prevent spondyloarthritis? Comorbidities in Axial Spondyloarthritis Do Disease Activity Measures Really Capture AS in Women?

Dr. Jack Cush and Dr. Arthur Kavanaugh discuss, dissect and deliberate the sessions and data presented at the ACR22 meeting in Philadelphia.

Wednesday - SpA Panelists: Drs. Lianne Gensler, Antoni Chan, Akhil Sood, Eric Dein, Sheila Reyes, Catherine Sims

Get the Skinny on Bimekizumab in PsA Dr. Janet Pope discusses abstract presented at ACR22 Convergence in Philadelphia, PA. L02: Bimekizumab Treatment in Biologic DMARD-Naïve Patients with Active Psoriatic Arthritis: 52-Week Efficacy and Safety Results from a Phase 3, Randomized, Placebo-Controlled, Active Reference Study Low dose steroids can negatively impact bone healthDr. Janet Pope discusses abstract L01 presented at ACR22 Convergence in Philadelphia, PA. L01: Impact of Glucocorticoid Dosing and Anti-Osteoporotic Treatment on Bone Health in Patients with Inflammatory Rheumatic Musculoskeletal Diseases: A Longitudinal Cohort Study The First Head to Head trial in Axial Spondyloarthritis Dr. Lianne Gensler discusses abstract L15 presented at ACR22 Convergence in Philadelphia, PA. L15: Effect of Secukinumab versus Adalimumab Biosimilar on Radiographic Progression in Patients with Radiographic Axial Spondyloarthritis: A Randomized Phase IIIb Study Why Clinical Trials? Dr. Guillermo Valenzuela talks about the importance of clinical trials from ACR22 Convergence in Philadelphia, PA.

RheumNow faculty to recap the best and most interesting data presented at ACR2022 in the area of PsA. Tuesday - PsA (7pm ET) Panelists: Drs. Rachel Tate, Robert Chao, Olga Petryna, Elaine Husni, Patricia Harkins

RheumNow faculty recap the best and most interesting data presented at ACR22 in RA. Panelists: Drs. Richard Conway, Aurelie Najm, David Liew, Janet Pope, Julian Segan

Autoimmunity Following COVID-19 Infection Dr. Akhil Sood discusses abstract 0795 at ACR22 Convergence. Abstract 0795: Post-Acute COVID-19 Sequalae (PACS) with New-onset Rheumatological Complications Best of ACR22 in PsA: Day Three Dr. Rachel Tate discusses the best PsA content presented on day three (Monday) at ACR22 Convergence in Philadelphia, PA. Medication Adherence intervention in SLE Dr. Bella Mehta speaks with Dr. Kai Sun abstract 0063 at ACR22 Convergence in Philadelphia, PA. Abstract 0063: Implementability of a SLE Medication Adherence Intervention Peresolimab for RA: Phase 2a Results Dr. Jonathan Kay abstract L03 at ACR22 Convergence in Philadelphia. L03: A Phase 2 Trial of Peresolimab for Adults with Rheumatoid Arthritis

ACR 2022 Daily Recap for Monday, November 14th.

Breakthrough COVID infection in RMD patients treated with Evusheld Dr. Yuz Yusof talks with Dr. Chris Podgorski at ACR22 Convergence. Lung Involvement in VEXAS Dr. Yuz Yusof and Dr. Marta Casal Moura discusses abstract 1569 presented at ACR22 Convergence. Abstract 1569: Lung Involvement in VEXAS Syndrome Reproductive health in a post-Roe world Dr. Robert Chao discusses abstract 1673 and L09 presented at ACR22 Convergence. Abstract 1673: Preconceptional NSAID Treatment Exposure Is Associated with a Significantly Longer Time-to-conception in Women with Spondyloarthritis: Analysis of the Prospective GR2 Cohort Abstract L09: Impact on Access to Methotrexate in the Post-Roe Era Stop Ordering Repeat ANAs! Dr. Kathryn Dao reviews abstracts 1278, 0228, and 0058 presented at ACR22 Convergence. Ultrasound in PsA Dr. Arthur Kavanaugh discusses abstract 2206 presented at ACR22 in Philadelphia. Abstract 2206: Understanding Inter-rater Variability in Scoring of Entheseal Lesions: Results from the Diagnostic Ultrasound Enthesitis Tool (DUET) Study What Happens after you stop biologics? Dr. Robert Chao discusses abstract 0427 presented at ACR22 convergence. Abstract 0427: Recapture Rates with Ixekizumab After Withdrawal of Therapy in Patients with Axial Spondyloarthritis: Results at Week 104 from a Randomized Placebo-controlled Withdrawal Study Which is better for AxSpA? IL-17i or TNFi? Dr. Robert Chao discusses abstract L15 presented at ACR22 Convergence.

Bouncebackability portends increased risk of adverse outcomes in RA Dr. Richard Conway discusses Abstract 2218 at ACR22 Convergence. Abstract 2218: Frailty Is Associated with Serious Infections in Biologic and Targeted-synthetic DMARD Treated Patients with Rheumatoid Arthritis Deucravacitinib in PsA Dr. Arthur Kavanaugh discusses abstract 1598 at ACR22 Convergence in Philadelphia. Abstract 1598: Safety and Efficacy of Deucravacitinib, an Oral, Selective Tyrosine Kinase 2 Inhibitor, in Patients with Psoriatic Arthritis: 52-Week Results from a Randomized Phase 2 Trial Efficacy and Safety Results from BE OPTIMAL in PsA Dr. Arthur Kavanaugh discusses abstract L02 ACR22 Convergence in Philadelphia, PA. L02: Bimekizumab Treatment in Biologic DMARD-Naïve Patients with Active Psoriatic Arthritis: 52-Week Efficacy and Safety Results from a Phase 3, Randomized, Placebo-Controlled, Active Reference Study Hydroxychloroquine Update from ACR22 Dr. Michelle Petri reviews several abstracts presented at ACR22 Convergence. Abstracts 0343, 0538, 0976, 0983, 0981, 0980 RA: Steroids are bad, again Dr. Richard Conway discusses Abstract 2219 at ACR22 Convergence Abstract 2219: Time-Dependent Evaluation of Glucocorticoid Exposure Duration and Major Adverse Cardiovascular Events in a Cohort of Veterans with Rheumatoid Arthritis Tapering TNFi in nonradiographic AxSpA Dr. Peter Nash at ACR22 Convergence in Philadelphia, PA. Tofacitinib and RA-ILD Dr. Richard Conway discusses Abstract 2251 at ACR22 Convergence. Abstract 2251: Reduction in Rheumatoid Arthritis-Associated Interstitial Lung Disease Risk in Patients Treated with Tofacitinib Life or Organ Threatening SLE: What To Do? Is There Anything New? Dr. Michelle Petri discusses Abstracts 1651, 1677 at ACR22 Convergence in Philiadelphia, PA.

Comorbidities in Axial Spondyloarthritis Dr. Antoni Chan discusses Abstract 1609 at ACR22 Convergence. Diffuse alveolar hemorrhage in antiphospholipid syndrome Dr. Eric Dein discusses Abstract 0675 at ACR22 Convergence. Abstract 0675: Clinical Characteristics and Factors Associated with Relapse and Mortality in Diffuse Alveolar Hemorrhage Among Patients with Antiphospholipid Syndrome: A Multi-Center Retrospective Cohort Eosinophilia in systemic JIA patients after exposure to biologics Dr. Bella Mehta discusses Abstract 0872 at ACR22 Convergence. Abstract 0872: Incidence, Risk Factors, and Outcomes of Eosinophilia on IL-1 and IL-6 Inhibitors in Systemic and Non-Systemic Juvenile Idiopathic Arthritis Gender differences in Axial Spondyloarthritis Dr. Antoni Chan covered abstracts 0497 and 1614 at ACR22 Convergence in Philadelphia, PA. Inadequate Dosing of Hydroxychloroquine Leads to Hospitalizations in SLE Dr. Sheila Reyes discusses abstract 1654 at ACR22 Convergence. Abstract 1654: Hydroxychloroquine Dosing Less Than 5 Mg/kg/day Leads to Increased Hospitalizations for Systemic Lupus Erythematosus Flares Oligoarticular PsA: FOREMOST Study Dr. Peter Nash discusses abstract 1018 at ACR22 Convergence. Abstract 1018: Characterization of Joint Distribution and Disease Burden in Patients with Early Oligoarticular Psoriatic Arthritis: Results from the Ongoing FOREMOST Study Sensor-engineered glove evaluates hand function in RA Dr. David Liew discusses abstract 0904 at ACR22 Convergence. Abstract 0904: Testing the Hand Function with a Sensor-engineered Glove in Patients with Rheumatoid Arthritis

Best of ACR Day Two in PSA Dr. Rachel Tate, discusses abstracts 1018, 1159 at ACR22 Convergence. Comorbidities in Ankylosing Spondylitis Dr. Akhil Sood discusses Abstract 1609 at ACR22 Convergence. Fat and bone are never alone: osteoporotic fracture in RA Dr. David Liew discusses Abstract 889 at ACR22 Convergence. Abstract 889: Serum Adipokines Predict Incident Osteoporotic Fracture in Patients with Rheumatoid Arthritis GCA: What we feel and what we can't Dr David Liew discusses Abstracts 0483 and 0486 at ACR22 Convergence. Hydroxychloroquine: Cumulative Doses and Thresholds Dr. Sheila Reyes discusses Abstracts 0982 and 0344 at ACR22 Convergence. JAK inhibitors in rheumatic diseases Dr. Antoni Chan discusses abstracts 0510 and 0404 at ACR22 Convergence in Philadelphia, PA. Abstract 0510: MACE and VTE Across Upadacitinib Clinical Trial Programs in Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis Abstract 0404: Site-Specific Responses of Joint and Entheses to Tofacitinib in Patients with Ankylosing Spondylitis: A Post Hoc Analysis of a Phase 3 Trial Low-grade Proteinuria in Non-Renal Lupus: Should We be Worried? Dr. Yuz Yusof discusses Abstract 1463 presented at ACR22 Convergence in Philadelphia, PA. PET CT Imaging to Define Risk of Progression from PSO to PsA Dr. Peter Nash discusses Abstract 1018 at ACR22 Convergence. Spondyloarthritis: Novel Therapies, Diagnostic Dilemmas and Depression Dr. Lianne Gensler discusses the following abstracts presented at ACR22 Convergence. Abstracts 1597, 1598, 1599 (treatment) and 1613, 1609 and 1614 (diagnosis and outcomes) Tapering TNF Inhib in non Radiolgraphic AxSpA Dr. Peter Nash, Philadelphia Vaccines Work! Dr. Eric Dein and Dr. Caoilfhionn Connolly discuss abstracts 2275 & 0797 at ACR22 Convergence.

Join RheumNow faculty to recap the best and most interesting data presented at ACR22 in the area of SLE. Sunday - SLE Panelists: Drs. Kathryn Dao, Bella Mehta, Yuzaiful Yusof, Eric Dein, Michael Putman, Sheila Reyes, Janet Pope

ACR 2022 Daily Recap for Sunday, November 13th.

AI Future of Sacroiliitis Assessment Dr. Rachel Tate speaks with Dr. Fabian Proft about Abstract 0383 at ACR22 Convergence. Can I stop Methotrexate in RA? Dr. Janet Pope and Dr. Charis Meng discuss Abstract 0916 at ACR22 Convergence. Abstract 0916: Should RA Patients with Controlled Disease Taper Methotrexate from Targeted Therapy or Continue It? Risk Differences in Sustaining Remission from a Systematic Review and Meta-analysis CAR-T Therapies in Antiphospholipid Antibody Syndrome Dr. Michael Putman and Dr. Maximilian Konig discuss abstract 1677 at ACR22 Convergence. Abstract 1677: Chimeric Autoantigen-T Cell Receptor (CATCR)-T Cell Therapies to Selectively Target Autoreactive B Cells Copays Reduce Adherence to SLE Medications Dr. Michael Putman reports on abstract 1115 at ACR22 Convergence in Philadelphia, PA. Copays Reduce Adherence to SLE Medications Dr. Michael Putman reports on abstract 1115 at ACR22 Convergence in Philadelphia, PA. Does Race play a role in Mycophenolate Response in Scleroderma? Dr. Eric Dein speaks with Dr. Lauren Smith about abstract 0521 at ACR22 Convergence in Philadelphia, PA. Abstract 0521: Examination of Differential Response to Treatment with Mycophenolate Mofetil in Black and White Patients with Systemic Sclerosis Fertility issues in SpA Dr. Sheila Reyes speaks with Dr. Sabrina Hamroun about abstract 1673 at ACR22 Convergence. Abstract 1673: Preconceptional NSAID Treatment Exposure Is Associated with a Significantly Longer Time-to-conception in Women with Spondyloarthritis: Analysis of the Prospective GR2 Cohort Opioid use in PsA and SpA Dr. Eric Dein discusses Abstract 1012 at ACR22 Convergence PsA and SPA: Cyclers, Switchers, Who is the Winner? Dr. Aurelie Najm discusses abstracts 1499 and 1600 at ACR22 Convergence in Philadelphia, PA. Remibrutinib in Sjogren's Syndrome Dr. Michael Putman reports on abstract 1113 presented at ACR22 Convergence meeting in Philadelphia, PA. Abstract 1113: Remibrutinib (LOU064) in Sjögren’s Syndrome: Safety and Efficacy Results from a 24‑Week Placebo-controlled Proof-of-Concept Study

Advancing Telehealth in Rheumatology Dr. Cush at ACR22 Convergence in Philadelphia, PA. Artificial Intelligence in Detecting Sacroiliitis Dr. Akhil Sood discusses Abstract 0383 at ACR22 Convergence. Abstract 0383: Analysis of the Performance of an Artificial Intelligence Algorithm for the Detection of Radiographic Sacroiliitis in an Independent Cohort of axSpA Patients Including Both Nr-axSpA and r-axSpA COVID Highlights Dr. Leonard Calabrese and Dr. Cassandra Calabrese share highlights on COVID data being presented at ACR22 Convergence. Abstract 0793: Autonomic Nervous System Dysfunction Common Among Patients with Long COVID: An Exploratory Evaluation Abstract L08: Breakthrough Acute COVID-19 Infection During the US Omicron Surge Following Administration of Tixagevimab/Cilgavimab in Immunocompromised Patients with Rheumatologic Disorders Impact of COVID 19 on Pregnancies in Women with RMD Dr. Cassy Sims discusses abstract 0950 at ACR22 Convergence. Abstract 0950: Obstetric Outcomes in Women with Rheumatic Disease and COVID-19 in the Context of Vaccination Status: Data from the COVID-19 Global Rheumatology Alliance Registry Photovoice: A New Visual Research Method in Lupus Dr. Bella Mehta talks with Dr. Candace Feldman about Abstract 1099 at ACR22 Convergence. Abstract 1099: Empowering Patients with Lupus Through Their Photographs: Application of the Photovoice Method to Understand Social Determinants of Health PreRA to Treat or Not! Dr. Janet Pope discusses the Great Debate at ACR22 Convergence in Philadelphia. Prescribing Methotrexate in Post-Roe Era Dr. Cassy Sims reports live from ACR22 Convergence in Philadelphia, PA. L09: Impact on Access to Methotrexate in the Post-Roe Era To Switch or Not: Biosimilars in Inflammatory Arthritis Dr. Jonathan Kay reports on abstract 1112 at ACR22 Convergence. Women vs. Men: Response to Treatment in Seronegative Arthritis Dr. Janet Pope discusses abstracts 1614 and 1601 at ACR22 Convergence in Philadelphia, PA

Advancing Telehealth in Rheumatology Dr. Cush at ACR22 Convergence in Philadelphia, PA. Artificial Intelligence in Detecting Sacroiliitis Dr. Akhil Sood discusses Abstract 0383 at ACR22 Convergence. Abstract 0383: Analysis of the Performance of an Artificial Intelligence Algorithm for the Detection of Radiographic Sacroiliitis in an Independent Cohort of axSpA Patients Including Both Nr-axSpA and r-axSpA COVID HighlightsDr. Leonard Calabrese and Dr. Cassandra Calabrese share highlights on COVID data being presented at ACR22 Convergence Abstract 0793: Autonomic Nervous System Dysfunction Common Among Patients with Long COVID: An Exploratory Evaluation Abstract L08: Breakthrough Acute COVID-19 Infection During the US Omicron Surge Following Administration of Tixagevimab/Cilgavimab in Immunocompromised Patients with Rheumatologic Disorders Impact of COVID 19 on Pregnancies in Women with RMD Dr. Cassy Sims discusses abstract 0950 at ACR22 Convergence. Abstract 0950: Obstetric Outcomes in Women with Rheumatic Disease and COVID-19 in the Context of Vaccination Status: Data from the COVID-19 Global Rheumatology Alliance Registry Photovoice: A New Visual Research Method in Lupus Dr. Bella Mehta talks with Dr. Candace Feldman about Abstract 1099 at ACR22 Convergence. Abstract 1099: Empowering Patients with Lupus Through Their Photographs: Application of the Photovoice Method to Understand Social Determinants of Health Prescribing Methotrexate in Post-Roe Era Dr. Cassy Sims reports live from ACR22 Convergence in Philadelphia, PA.3 L09: Impact on Access to Methotrexate in the Post-Roe Era Treatment Persistence and Switching Patterns of an Adalimumab Biosimilar Dr. Julian Segan discusses Abstract 1425 at ACR22 Convergence. Abstract 1425: Treatment Persistence and Switching Patterns of ABP 501 (AMGEVITA®) in German Patients with Rheumatic Diseases

Can we alter neonatal gut microbiome to prevent spondyloarthritis? Dr Chao discusses Abstract 0868 at the ACR22 Convergence meeting. Abstract 0868: Spondyloarthritis and Neonatal Factors Affecting the Gut Microbiome JAK vs TNF inhibitor Infections in RA Dr. David Liew discusses abstract 0302 at ACR22 Convergence. Abstract 0302: Risk of Infections Between JAK Inhibitors and TNF Inhibitors Among Patients with Rheumatoid Arthritis Opioid and Neuropathic Use After Initiating btsDMARDs in RA Dr. Julian Segan discusses Abstract 0925 at the ACR22 Convergence meeting. The Dietary Intervention in PsA (DIPSA) StudyDr. Patricia Harkins talks with Professor Lihi Eder about abstract 1007 at the ACR22 Convergence meeting. Abstract 1007: Metabolic Disorders and Abnormal Dietary Patterns and Their Association with Psoriatic Arthritis Activity: The Dietary Intervention in PsA (DIPSA) Study Treatment Considerations in Axial Spondyloarthritis Dr. Lianne Gensler discusses treatment considerations in Axial SpA. Abstract 0402: Opioid Use and Healthcare Utilization in Adults with PsA and AS Abstract 0388: Incidence Rate and Factors Associated with Fractures Among Older Adults with Ankylosing Spondylitis in the United States Abstract 0544: Bimekizumab Improves Signs and Symptoms, Including Inflammation, in Patients with Active Non-Radiographic Axial Spondyloarthritis: 24-Week Efficacy & Safety from a Phase 3, Multicenter, Randomized, Placebo Controlled Study Abstract 0545: Continuing (Full or Reduced Treatment) versus Withdrawing from Golimumab Treatment in Patients with Non-radiographic Spondylarthritis Who Achieved Inactive Disease: Efficacy and Safety Results from a Placebo-Controlled, Randomized Withdrawal and Retreatment Study (GO-BACK) What lifestyle factors affect TNF inhibitor efficacy in AxSpA? Dr Chao discusses Abstract 1510 at ACR22 Convergence. Abstract 1510: Modifying Lifestyle Factors May Offer the Potential to Enhance the Outcome of Tumour Necrosis Factor Inhibitors in Axial Spondyloarthritis – Data from 14 European Countries

2023 RWCS Meeting Dr. Arthur Kavanaugh invites you to join him for the 2023 RWCS meeting in February 2023. Dr David Liew JAK inhibitor VS TNF inhibitor, Infections in East Asian Patients. Abstract 302 Early Diagnosis of Axial Spondyloarthritis Dr. Antoni Chan talks with Dr. Nelly Ziade at ACR22 Convergence in Philadelphia, PA. Abstracts 1512: What Is the Best Referral Strategy for Axial Spondyloarthritis? A Prospective Multicenter Study of 515 Patients with Suspicious Chronic Low Back Pain Abstract 1517: Value of the Anti-CD74 Antibodies for the Diagnosis of Axial Spondyloarthritis: Results of a Prospective Study in Patients with Suspicious Low Back Pain New Treatments for SLE? Dr. Michelle Petri discusses abstract 1117 presented at ACR22 Convergence meeting in Philadelphia, PA. Abstract 1117: Efficacy and Safety of Deucravacitinib, an Oral, Selective, Allosteric TYK2 Inhibitor, in Patients with Active Systemic Lupus Erythematosus: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study

ACR2022 Daily Recap for Saturday, November 12th.

Breakthrough COVID infection in SLE during Omicron era Dr. Yusof talks with Dr. Amit Saxena about abstract 2081 at ACR22 Convergence. Abstract 2081: COVID-19 Infections, Morbidity, and Seroreactivity in SLE Patients Following Initial Vaccination Series and Additional Dose Through the New York City Omicron BA.1 Wave Differences in Presentation and Outcomes of Early vs Late Onset PsA Dr. Olga Petryna discusses abstract 0377 presented at ACR22 Convergence. Abstract 0377: Differences in Early-onset vs. Late-onset Psoriatic Arthritis: Data from the RESPONDIA and REGISPONSER Studies

A Year in Review Dr. Jack Cush, Philadelphia Differences in Clinical Presentation and Outcomes of Early vs Late Onset PsA Dr. Olga Petryna, New York Abstract 0377 mTORC1 as a Driver of Inflammation in sJIA Connecting Pathogens of sJIA and MAS Dr. Olga Petryna, New York Abstract 0004 Patient Reported Outcomes in PsA Using Novel IL 17A Inhibitor Dr. Sims discusses abstract 0199 presented at ACR22 Convergence in Philadelphia, PA. Abstract 0199: Izokibep, a Novel IL-17A Inhibitor, Improves Patient-reported Outcomes – 16-Week Results from a Placebo-controlled Phase 2 Study in Patients with Active Psoriatic Arthritis The CONSUL Trial Dr. Sheila Reyes, The Phillipines Abstract 0526

Best of PsA on Day 1 Dr. Rachel Tate discusses the best PSA data presented Saturday, November 12, 2002 at ACR22 Convergence. Abstract 0387: Sleep Quality in Patients with Psoriatic Arthritis and Its Relationship with Activity and Comorbidity Abstract 0377: Differences in Early-onset vs. Late-onset Psoriatic Arthritis: Data from the RESPONDIA and REGISPONSER Studies Can computers tell the difference between RA & PsA? Dr. David Liew discusses Abstract 0242 presented at ACR22 in Philadelphia, PA. Abstract 0242: Neural Networks for Distinguishing Rheumatoid Arthritis from Psoriatic Arthritis by Using Magnetic Resonance Imaging Can you use the BASDAI in Pregnancy? Dr. Eric Dein discusses abstract 0374 presented at ACR22 Convergence in Philadelphia, PA. Abstract 0374: The BASDAI Index During Pregnancy Drs Tate and Worthing What's going on on the Hill Session # 12S119. Effect of voclosporin in class V lupus nephritis Dr. Yusof discusses abstract 0355 presented at ACR22 Convergence in Philadelphia, PA. Abstract 0355: Long-term Use of Voclosporin in Patients with Class V Lupus Nephritis: Results from the AURORA 2 Continuation Study Microbiome and AxSPA Dr. Akhil Sood discusses abstract 1162 presented at ACR22 Convergence in Philadelphia, PA. Abstract 1162: Improvement of Gut Microbiota Dysbiosis in Patients with Axial Spondyloarthritis After One Year of Biological Treatment Opioids and Health Care Utilization in PsA and AS Dr Aurelie Najm discusses Abstract 0402 presented at ACR22 Convergence in Philadelphia, PA. Abstract 0402: Opioid Use and Healthcare Utilization in Adults with PsA and AS Switching Between JAK Inhibiters in RA Dr. Janet Pope discusses abstract 0274 presented at ACR22 Convergence in Philadelphia, PA. Abstract 0274: Real-world Utilisation and Switching Between Janus Kinase Inhibitors in Patients with Rheumatoid Arthritis in the Australian OPAL Dataset Treatment Choices and Mortality in RA ILd 2 Dr. Julian Segen, Philadelphia Dr. Bryant England, Philadelphia Upadacitinib vs Adalimumab in PsA using RAPID3 Dr. Catherine Sims discusses abstract 0192 presented at ACR22 Convergence. 0192: Upadacitinib versus Adalimumab on Routine Assessment of Patient Index Data 3 (RAPID3) in Patients with Psoriatic Arthritis

Frailty in Vasculitis Dr. Patricia Harkins sits down with Professor Sebastian Sattui to discuss Abstract 0444, Prevalence of Frailty and Associated Factors in Patients with Vasculitis, being presented on Saturday at ACR22 Convergence. Lupus, Sex and STDs Dr. Kathryn Dao discusses abstract 0939 presented at the ACR22 Convergence meeting in Philadelphia, PA. Abstract 0939: Pilot Study: A Novel Method for Cervical Health Monitoring in African American Women with Systemic Lupus Erythematosus (SLE) Using a Self- Sampling Brush to Assess Cervical HPV Infection and Cervical Cytology Much gusto for GUSTO: Efficacy of Tocilizumab Monotherapy for Giant Cell Arteritis Dr. Richard Conway discusses abstract 0470, being presented during Poster Session A on Saturday, November 12, 2022 at the ACR 2022 meeting. Abstract 0470: Long-term Efficacy of Tocilizumab Monotherapy After Ultra-short Glucocorticoid Administration to Treat Giant Cell Arteritis – One Year Follow-up of the GUSTO Trial NSAIDs and CV risk in Inflammatory Arthritis Dr. Richard Conway discusses abstract 1207, being presented during Poster Session C on Sunday, November 13, 2022 at the ACR 2022 meeting. Abstract 1207: Risk Factors for Major Cardiovascular Events (MACE) in Inflammatory Arthritis: A Time-dependent Analysis on the Inflammatory Burden, Use of DMARDs, NSAIDs, and Steroid Should You Repeat the ENA Panel? Dr. Kathryn Dao discusses abstract 0725, presented at ACR22 Convergence. Abstract 0725: Utility of Repeat Extractable Nuclear Antigen Antibody Testing- a Retrospective Audit To Beta Block or Not in GCA and Large Vessel Vasculitis Dr. Patricia Harkins discusses abstract 0477 presented on Saturday, November 12, 2022, at ACR22 Convergence. Abstract 0477: Can Beta-blockers Prevent Aortic Dilation in Patients with Giant Cell Arteritis and Large Vessel Vasculitis? A Novel Treatment Response Measurement Tool for Lupus Dr. Kathryn Dao discusses abstract 2054 with Dr. Eric Morand at the ACR22 Convergence meeting. Abstract 2054: Towards a Novel Clinician-Reported Outcome Measure for SLE – Outcomes of an International Consensus Process Sarilumab in Polymyalgia Rheumatica: Results from Phase 3 Trial Dr. Michael Putman interviews Dr. Robert Speira about abstract 1676 presented at the ACR22 Convergence meeting in Philadelphia, PA. Abstract 1676: Sarilumab in Patients with Relapsing Polymyalgia Rheumatica: A Phase 3, Multicenter, Randomized, Double Blind, Placebo Controlled Trial (SAPHYR) Welcome to ACR 2022 Dr. Jack Cush, Executive Editor of RheumNow, welcomes you to Philadelphia for ACR22 Convergence! 2022 ACR/EULAR Classification Criteria for GCA Dr. Michael Putman discusses interesting take-home messages from the Vasculitis Investigators Meeting at ACR22 Convergence regarding the 2022 ACR/EULAR Classification Criteria for GCA. Gender in AxSpa Dr. Peter Nash, Philadelphia Do Disease Activity Measures Really Capture AS in Women? Dr. Rachel Tate interviews Dr. Sinead Mcguire about Abstract 0406, presented at ACR22 Convergence in Philadelphia, PA. Abstract 0406: https://acrabstracts.org/abstract/are-the-basdai-basfi-capturing-the-full-impact-of-disease-activity-on-quality-of-life-in-women-with-axial-spondyloarthritis/ Dr Aurelie Najm Opoids and health care utilization in PsA and AS Abstract 402 Poor Medication Adherence in SLE and How to Improve It Dr. Janet Pope discusses three abstracts presented at the ACR22 Convergence meeting in Philadelphia, PA. 0343: Severe Non-adherence to Hydroxychloroquine Is Associated with Flares, Early Damage, and Mortality in Systemic Lupus Erythematosus: Data from 660 Patients from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort 0115: Facilitators of Immunosuppressive Medication Adherence in Systemic Lupus Erythematosus: A Qualitative Study of Racial Minority Patients, Lupus Providers and Clinic Staff 0063: Implementability of a SLE Medication Adherence Intervention Sputum anti-CCP the new diagnostic test in at-risk RA? Dr. Aurelie Najm discusses abstract 0533 at the ACR22 Convergence meeting in Philadelphia, PA. Abstract 0533: Sputum RA-Associated Autoantibodies Independently Associate with Future Development of Classified RA in an At-Risk Cohort of Individuals with Systemic Anti-CCP Positivity Drs Cush and Fava: Urinary Biomarkers in Lupus Dr. Jack Cush interviews Dr. Andrea Fava about Abstract 536 at the ACR22 Convergence meeting in Philadelphia, PA. Abstract 0536: Change in Urinary Biomarkers at Three Months Predicts 1-year Treatment Response of Lupus Nephritis Better Than Proteinuria Social Media in Rheumatology Academia Dr. Kathryn Dao, Dallas Jorena Lim, third-year medical student, UTSW, Dallas Abstract 0220 Treatment Choices and Mortality in RA ILd Dr. Julian Segen, Philadephia Dr. Bryant England, Philadephia Dr Tate PsA Cycling or Switching MOAs with Dr Ogdie Abstracts 1600 and 402. Dr Cassy Sims The Impact of Upacitinib vs Adalimumab in Psoriatic Arthritis using RAPID Abstract 192. Urinary Bi

Dr Jack Cush reviews the news and journal reports from the past week on RheumNow.com and looks forward to highlight sessions in the next few days at ACR Convergence 2022.

QD201 - Seropositive Arthralgia (abstract #1604) https://youtu.be/uQt_IV3FmZc QD202 -1st Line Anakinra (abstract #L12) https://youtu.be/QyDVQBnYqn4 QD203 - When to Worry About Malignancy and Myositis (abstract #002) https://youtu.be/qt-debWfSrY QD204 How to Treat Erosive OA (abstract #L05) https://youtu.be/5-atRyBsCn4 QD205 - RA Activity During Pregnancy (abstract #0955) https://youtu.be/wavTWqZbhq4

Dr. Jack Cush reviews the news and journal articles from this past week on RheumNow.com. New regulatory decisions about JAK inhibitors and why do women with rheumatic diseases have unfair outcomes?

Dr. Nimesh Dayal (Orlando Health-Health Central Hospital, Orlando, FL) discusses the relevance of clinical endpoints and guidelines for ax-SpA in clinical practice.

Dr. Jack Cush discussess the news and journal reports from the past week on RheumNow.com . This week more lupus nephritis, more drug induced lupus and more lupus infections that may kill.

Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com. Highlighted discussion of implantable stimulators, urine proteomics and gut-immune responses to Prevotella in RA.

Review of Adult-onset Still's Disease by Dr. Jack Cush, Executive Editor of RheumNow.com

Dr. Jack Cush reviews: - Should you do clinical trials? - how to start in clinical trials - Types of studies - Benefits to research

Dr. Jack Cush goes off on "Untitling" (not using proper names/titles) in the clinic, in additon to reports on rheumatologist salaries, new drugs in phase 1-3 development and the range of COVID-19 MSK symptoms -- all from the past week on RheumNow.com.

Drs. Pendleton Wickersham (Arthritis Associates PA, San Antonio, TX), Kevin Winthrop (OHSU, Portland, OR), and Christopher Ritchlin (URMC, Rochester, NY) come together to share their experiences discussing with patients the benefit-risk of a JAK inhibitor.

Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.

Thanks to all of you for your kind comments and great reviews of our weekly podcast. Please let us know how we can improve by emailing me ([email protected]) or recording your suggestion using the "Ask Cush Anything" link on our email and website.

Dr. Jack Cush reviews the news, journal reports, ACR and FDA announcements from the past week on RheumNow.com

Can we predict the bad outcomes? Like when ITP evolves into SLE; or when psoriasis will develop arthritis; or if Sjogens will develop lymphoma? Dr. Jack Cush reviews these journal reports and this past weeks news from RheumNow.com

Featuring a discussion with Dr. Susan Shenoi from Seattle Childrens Hospital

Dr. Jack Cush discusses declining survival rates in the USA, FDA approvals of new COVID subvariant boosters and other odd and possibly true new research reports from the past week on RheumNow.com.

Rainbow Rheumatology (8.26.2022) Dr. Jack Cush delivers this weeks rheumatology "weather report" with the best and least of news and journal articles from the past week on RheumNow.com “Climate is what we expect, weather is what we get.” – Mark Twain

Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow and discusses a case of refractory juvenile dermatomyositis with calcinosis.

Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow.com. This week the run down is based on popularity, measured by rheumatologist engagements on the website and social media.

Dr. Jack Cush reviews the news, FDA approvals, journal articles from the past week on RheumNow; plus viewer questions. This week great hopes for vitamin D, the great unknows of CSA and the great big mess that is the gout.

Drs. Jack Cush and Rachel Tate discuss the launch of the updated StillsNow.com website and the new monthly podcast from StillsNow.com. This podcast ends with a Still's disease quiz for rheumatologists.

QD197 - Still's (or Not) NEJM CPC https://youtu.be/_xnCaxeqidw QD198 - Still's (or Not) with Daily Fevers https://youtu.be/J1bezuA-f_s QD199 - Still's (or Not): an FUO Evaluation https://youtu.be/0qDijCAqEpQ QD200 - Still's (or Not): Fever, Joint pain & Itchy Eyes https://youtu.be/utvFA1lx1lc

Dr. Jack Cush reviews the news, journal reports and rheumatologist cases from the past week on RheumNow.com. This podcast is brought to you by StillsNow.com - be sure to sign up for our monthly StillsNow email and Monthly StillsNow Podcast.